
Perspective Therapeutics, Inc.
CEO
Johan Spoor
IPO Date
2005-11-10
Sector
Healthcare
Industry
Medical - Devices
Exchange
AMEX
Country
US
| 50,000 |
| $5.35 |
| 4 Mar 2026 | Williamson Robert F III | director | A-Award | Acquired | 50,000 | $5.35 |
| 4 Mar 2026 | HENSON HEIDI | director | A-Award | Acquired | 50,000 | $5.35 |
| 4 Mar 2026 | Woods Lori A | director | A-Award | Acquired | 50,000 | $5.35 |
| 4 Mar 2026 | Spoor Johan M. | director, officer: Chief Executive Officer | A-Award | Acquired | 735,000 | $5.35 |
| 4 Mar 2026 | Hunt Jonathan Robert | Chief Accounting Officer | A-Award | Acquired | 90,000 | $5.35 |
| 4 Mar 2026 | Puhlmann Markus | Chief Medical Officer | A-Award | Acquired | 150,000 | $5.35 |
| 17 Nov 2025 | Hunt Jonathan Robert | Chief Accounting Officer | P-Purchase | Acquired | 11,000 | $2.03 |
| 14 Nov 2025 | Williamson Robert F III | director | P-Purchase | Acquired | 9,498 | $2.10 |